Creative Planning Exagen Inc. Call Options Transaction History
Creative Planning
- $116 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding XGN
# of Institutions
52Shares Held
9.08MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$15.5 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$7.78 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$6.57 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA682KShares$6.23 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$4.86 Million0.03% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $149M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...